// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Reliability and Responsiveness of the Standardized Universal Pain Evaluations for Rheumatology Providers for Children and Youth (SUPER-KIDZ)

Jennifer Stinson - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

SUMMACTA: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy of Tocilizumab SC versus Tocilizumab IV, in Combination with Traditional DMARDs in Patients with Moderate to Severe RA

Andrea Rubbert-Roth - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tocilizumab

New Online Resource for Promotion and Dissemination of Collaborative Research Results to the Public

Raquel Sweezie - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Radiographs and MRI are Inaccurate in Assessment of Ulnar Deviation in Rheumatoid Arthritis Patients Regina

Allison Mitchell - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Caerebrovascular and Peripheral Vascular Involvement in Kimur-s Disease

Navjot Dhindsa - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Actigraphic Evaluation of Periodic Limb Movements in RA Patients with and without Symptoms of Restless Legs Syndrome

Regina Taylor-Gjevre - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Restless Legs syndrome

N/A

Perceived Barriers to Health Care for RA Patients in Northern Saskatchewan

Regina Taylor-Gjevre - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

How Low is Low Disease Activity? An Analysis from the Prospective, Observational Registry, BioTRAC

Boulos Haraoui - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Infliximab

Participant and Educator Feedback Informs Delivery of an Inflammatory Arthritis Education Program using Telemedicine in Rural Communities

Kelly Warmington - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Canadian Rheumatology Association Choosing Wisely CRA Choosing Wisely Commitee

Shirley L. Chow - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Giant Peculiarity: Giant Cell Arteritis without an Elevated ESR or CRP

Sandra Dumanski - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pulmonary Sarcoidosis, a Complication of Etanercept Treatment in Inflammatory Arthritis: A Report of Five Cases

Scott Rapske - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Etanercept

Anti-RNA Polymerase III Antibodies in the Diagnosis of Scleroderma Renal Crisis Sine Scleroderma

Raj Carmona - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Variability in the Classification of Remission Among Disease Activity Indices and their Correlation: An Analysis from a Prospective, Observational Registry

Algis Jovaisas - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Infliximab

Assessment of Rheumatoid Arthritis Disease Activity by Patients and Physicians: Do Physicians Detect Improvement Before the Patient Does?

Carter Thorne - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Infliximab

Does Low Disease Activity at Six Months Predict Remission at 12 Months in Rheumatoid Arthritis Patients Treated with Biologics in a RealWorld Setting?

Philip Baer - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Infliximab

Psoriatic Arthritis and Swee-s Syndrome: A Case Report and Review of the Literature

Iman Hemmati - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Electronic Web-Based Rheumatologic Assessment Tool to Improve Communication with Allied Health Professionals: A 12 Month Pilot Project.

Igal Raizman - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Impact of Male Sex on Survival in Systemic Sclerosis

Sindhu Johnson - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Effects of Rituximab and Infliximab on Carboxypeptidase B and its Substrates in Rheumatoid Arthritis Synovium

Hani El-Gabalawy - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Infliximab

Copyright © 2026. QuantiNova All rights reserved